Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.taap.2007.05.013
Title: Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: A possible role in statin-induced hepatotoxicity?
Authors: Tavintharan, S.
Lim, S.C.
Ong, C.N. 
Jeyaseelan, K. 
Sivakumar, M.
Sum, C.F.
Keywords: Hepatotoxicity
Oxidative stress
Statins
Transaminitis
Ubiquinone
Issue Date: 2007
Citation: Tavintharan, S., Lim, S.C., Ong, C.N., Jeyaseelan, K., Sivakumar, M., Sum, C.F. (2007). Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin: A possible role in statin-induced hepatotoxicity?. Toxicology and Applied Pharmacology 223 (2) : 173-179. ScholarBank@NUS Repository. https://doi.org/10.1016/j.taap.2007.05.013
Abstract: Lowering of low-density lipoprotein cholesterol is well achieved by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins). Statins inhibit the conversion of HMG-CoA to mevalonate, a precursor for cholesterol and coenzyme Q10 (CoQ10). In HepG2 cells, simvastatin decreased mitochondrial CoQ10 levels, and at higher concentrations was associated with a moderately higher degree of cell death, increased DNA oxidative damage and a reduction in ATP synthesis. Supplementation of CoQ10, reduced cell death and DNA oxidative stress, and increased ATP synthesis. It is suggested that CoQ10 deficiency plays an important role in statin-induced hepatopathy, and that CoQ10 supplementation protects HepG2 cells from this complication. © 2007 Elsevier Inc. All rights reserved.
Source Title: Toxicology and Applied Pharmacology
URI: http://scholarbank.nus.edu.sg/handle/10635/24481
ISSN: 0041008X
10960333
DOI: 10.1016/j.taap.2007.05.013
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.